GENORAY Receives 'Minister of Health and Welfare Commendation' at KIMES 2026 (2026.03.23)

GENORAY, a global leader in X-ray imaging diagnostic medical devices, announced on the 23rd that its participation in KIMES 2026, the International Medical Equipment & Hospital Equipment Exhibition, confirmed its technological competitiveness and potential for expanded contracts in both domestic and global markets.

GENORAY has established itself as a leading company in the diagnostic imaging equipment sector, holding the number one domestic market share across its entire medical product lineup (C-Arm, Mammography, ENT CBCT). This technological prowess and market competitiveness drew significant interest from domestic and international medical professionals at KIMES 2026.

The exhibition featured key products including the strategic C-Arm models 'BELLIGER ACE' and 'OSCAR 15FD', as well as the next-generation ENT model 'Ovello'. In particular, 'BELLIGER ACE' and 'OSCAR 15FD' received significant attention, with medical institution representatives requesting numerous consultations and demonstrations throughout the event. 'Ovello', an ENT model equipped with a larger detector than previous versions, also received a positive response on-site.

GENORAY recently obtained CE MDR certification for its entire C-Arm lineup, including the 'OSCAR 15FD' and 'BELLIGER ACE'. This certification is a key standard for entering the European market and serves as a driver for global expansion. With demand for high-end models increasing, it is reported that discussions regarding business cooperation took place at the exhibition, with some overseas partners even considering bulk purchases. Consequently, contract expansions in the global market are continuing, and revenue growth in the C-Arm sector is becoming increasingly visible.

Meanwhile, Lee Seok-jin, a director at the research institute, was awarded the Minister of Health and Welfare Commendation at the opening ceremony in recognition of his leadership in successfully executing national projects and securing key technologies.

A GENORAY representative stated, "Through KIMES 2026, we have confirmed the potential for cooperation with global partners and opportunities for market expansion," adding, "We plan to accelerate our global sales growth, starting with our entry into the European market based on our CE MDR certification."